Acute coronary syndromes in black Americans: is treatment different? Should it be?

Luther T Clark1, Umesh Lingegowda

  • 1Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA. ltclark@downstate.edu

Insights

Black Americans with acute coronary syndromes (ACS) face higher risks and worse outcomes. Despite guidelines, they receive less aggressive treatment and fewer cardiac interventions compared to white Americans.

Area of Science:

  • Cardiology
  • Health Disparities
  • Clinical Medicine

Background:

  • Black Americans experience a disproportionately higher risk and poorer outcomes from acute coronary syndromes (ACS) compared to White Americans.
  • Contributing factors include a greater burden of baseline risk factors, delayed medical care seeking, and underutilization of aggressive treatments in high-risk individuals.

Purpose of the Study:

  • To investigate the disparities in treatment and outcomes for Black Americans experiencing acute coronary syndromes (ACS).
  • To highlight the paradox of Black patients with ACS receiving less aggressive care despite higher risk.

Main Methods:

  • Comparative analysis of treatment strategies and outcomes based on race in patients with acute coronary syndromes (ACS).
  • Review of risk factors, patient delays, and utilization of cardiac interventions (catheterization, PCI, bypass surgery).

Main Results:

  • Black Americans with ACS paradoxically receive less aggressive medical therapy compared to White Americans.
  • Black patients are less frequently referred for critical cardiac interventions such as cardiac catheterization, percutaneous coronary interventions (PCI), and bypass surgery.

Conclusions:

  • Current treatment patterns for ACS in Black Americans are suboptimal and require significant improvement.
  • Effective strategies are needed to reduce patient delays, ensure earlier diagnosis, and implement evidence-based guidelines more equitably for Black patients with ACS.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...